Congratulations to the fourteen UHN researchers who have made the 2022 list of Highly Cited Researchers from Clarivate—a global leader in bibliometrics and analytics. Only 6,938 researchers from 69 countries were awarded the distinction.
A citation (i.e., when a scientific article references a previously published article) is an objective measure of how influential a publication is within a particular field. The Clarivate Highly Cited Researcher list recognizes individuals who published highly cited papers that rank in the top 1% by citations for field and publication year in the Web of Science citation index over the past decade. Seven UHN researchers on the list received the added distinction of being included in the ‘Cross-Field’ category, reflecting their interdisciplinary excellence and impact in multiple research fields.
Dr. Brad Wouters, Executive Vice-President of Science and Research at UHN, comments, “These highly cited researchers represent exceptional leaders. Through their research, they are making waves within the international scientific and medical communities. Their discoveries are also leading to new and improved therapies that are making our vision of A Healthier World a reality. We are proud of them, and it is an honour to celebrate their achievements.”
The list of UHN researchers and the categories in which they received their distinction are listed below. To read more, see the Clarivate press release.
Cheryl Arrowsmith | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: cancer-related structural biology, chemical biology and epigenetics.
Gary Bader | Biology and Biochemistry
Affiliate Scientist, Princess Margaret Cancer Centre
Research focus: bridging molecular and clinical datasets to identify clinically relevant targets of cancer and regenerative wound healing processes.
Eddy Fan | Clinical Medicine
Scientist, Toronto General Hospital Research Institute
Research focus: advanced life support for acute respiratory failure and patient outcomes from critical illness.
Slava Epelman | Immunology
Senior Scientist, Toronto General Hospital Research Institute
Research focus: the contribution of immune cells to cardiac tissue injury and repair.
Steven Gallinger | Cross-Field
Clinician Scientist, Princess Margaret Cancer Centre
Research focus: cancer genetics, including gastrointestinal, colorectal and pancratic cancers.
Gordon Keller | Cross-Field
Senior Scientist, McEwen Stem Cell Institute and Princess Margaret Cancer Centre
Research focus: the application of developmental biology-guided principles to the differentiation of pluripotent stem cells into therapeutically relevant cells, such as cardiomyocytes, hematopoietic cells and liver cells.
Sidney Kennedy | Psychiatry and Psychology
Senior Scientist, Krembil Brain Institute
Research focus: the application of deep brain stimulation to treatment-resistant depression, including clinical trials and the development of treatment guidelines.
Anthony Lang | Neuroscience and Behavior
Senior Scientist, Krembil Brain Institute
Research focus: the etiology and pathogenesis of Parkinson disease and related movement disorders, as well as related novel diagnostics, and disease-modifying and symptomatic therapies.
Natasha Leighl | Cross-Field
Clinician Investigator, Princess Margaret Cancer Centre
Research focus: novel therapeutics and diagnostics for thoracic cancers, including early phase trials.
Andres Lozano | Cross-Field
Senior Scientist, Krembil Brain Institute
Research focus: brain mapping, deep brain stimulation (DBS) and focused ultrasound (FUS) in patients and experimental models of brain diseases.
Tak Mak | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: the mechanisms underlying immune responses, the pathogenesis and tumorigenesis of cancer.
Roger McIntyre | Psychiatry and Psychology
Clinician Investigator, Krembil Brain Institute
Research focus: the effects of mood disorders on cognitive function, related health conditions and workplace functioning.
Frances Shepherd | Clinical Medicine
Senior Scientist, Princess Margaret Cancer Centre
Research focus: the design and conduct of research studies evaluating the new targeted agents and anti-angiogenesis agents in lung cancer.
Ming-Sound Tsao | Cross-Field
Senior Scientist, Princess Margaret Cancer Centre
Research focus: the mechanisms of non-small cell lung cancer, including how it metastasizes (i.e., its ability to spread throughout the body), its resistance to therapy and the small subpopulations of tumour cells that can evade treatments.